Cargando…
The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients
OBJECTIVE: Multiple myeloma (MM) is a highly characteristic tumor that is influenced by numerous factors that determine its prognosis. Studies indicate that the presence of circulating plasma cells (cPCs) is a detrimental factor that significantly impacts the prognosis of patients with MM. METHODS:...
Autores principales: | Yao, Weiqin, Yang, Haifei, You, Hongying, Shang, Jingjing, Zhai, Yingying, Yan, Zhi, Yan, Shuang, Shi, Xiaolan, Yao, Ying, Wang, Jing, Wang, Panfeng, Xu, Yun, Jin, Song, Yan, Lingzhi, Wu, Depei, Fu, Chengcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548821/ https://www.ncbi.nlm.nih.gov/pubmed/37799469 http://dx.doi.org/10.3389/fonc.2023.1266868 |
Ejemplares similares
-
The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients
por: You, Hongying, et al.
Publicado: (2022) -
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment
por: Zhou, Shiyuan, et al.
Publicado: (2023) -
Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma
por: Yan, Lingzhi, et al.
Publicado: (2020) -
Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells
por: Yan, Lingzhi, et al.
Publicado: (2019) -
Prognostic significance of CD56 antigen in newly diagnosed multiple myeloma: A real-world retrospective study
por: Li, Liping, et al.
Publicado: (2022)